āĻšā§āĻŽSRPT âĸ NASDAQ
add
Sarepta Therapeutics Inc
ā§§ā§Šā§Š.ā§Šā§Ē$
āĻāĻŖā§āĻāĻž āĻĒāĻ°ā§:(ā§Ļ.ā§Ļā§Ļ%)ā§Ļ.ā§Ļā§Ļ
ā§§ā§Šā§Š.ā§Šā§Ē$
āĻŦāĻ¨ā§āĻ§ āĻāĻā§: ā§§ā§Ģ āĻāĻ, ā§Ģ:ā§Ļā§Ģ:ā§Ļā§Ģ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§Šā§Š.ā§Ļā§Ž$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Šā§¨.ā§§ā§¨$ - ā§§ā§Šā§Ģ.ā§ā§Ļ$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Ģā§Ģ.ā§¨ā§Ģ$ - ā§§ā§ā§Š.ā§¨ā§Ģ$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§¨.ā§ā§¨āĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§ā§Š.ā§¨ā§§Â āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§Šā§§ā§¯.ā§¯ā§Š
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Šā§Ŧ.ā§¨ā§¯Â āĻā§ | ā§Šā§Ž.ā§¯ā§Š% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§§ā§Š.ā§¯ā§Ē āĻā§ | ā§§ā§.ā§Šā§¯% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ŧā§Ē.ā§Ŧā§Ļ āĻ˛āĻž | ā§§ā§¨ā§Ŧ.ā§¯ā§Ž% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§§.ā§ā§Ž | ā§§ā§§ā§¯.ā§Ēā§Š% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ļ.ā§Ēā§Ē | ā§§ā§Ģā§§.ā§ā§Ŧ% |
EBITDA | ā§Žā§Ļ.ā§§ā§ŽÂ āĻ˛āĻž | ā§§ā§Ļā§Ŧ.ā§Ģā§Š% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§Ģā§¨.ā§Ēā§¨% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§§ā§Ēā§Ŧ.ā§Ļā§Ģ āĻā§ | -ā§¨ā§§.ā§Ģā§§% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Šā§Ēā§¨.ā§Ēā§ŠÂ āĻā§ | ā§¯.ā§Ģā§Ģ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§Šā§Ē.ā§ā§¨Â āĻā§ | -ā§§.ā§Ģā§Ŧ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§Ļā§.ā§ā§§Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¯.ā§Ģā§Ē āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§§ā§§.ā§ā§Ž | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§Ļā§Ģ% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§Ļā§% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ŧā§Ē.ā§Ŧā§Ļ āĻ˛āĻž | ā§§ā§¨ā§Ŧ.ā§¯ā§Ž% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§§.ā§Ēā§¯Â āĻā§ | ā§§ā§§ā§¨.ā§¨ā§¨% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¯.ā§Žā§Ģ āĻā§ | -ā§¨ā§Ļā§§.ā§¯ā§Ŧ% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Š.ā§¯ā§¯Â āĻā§ | ā§Ģā§Žā§§.ā§Ļā§Ž% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§Ē.ā§Šā§Â āĻā§ | -ā§§ā§¨ā§§.ā§¨ā§Š% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§¨.ā§¯ā§Ģ āĻā§ | -ā§Šā§Ēā§Ē.ā§Ŧā§% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§Žā§Ļ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§,ā§Šā§§ā§Ē
